Concepedia

Reactogenicity, safety, and immunogenicity of chimeric haemagglutinin influenza split-virion vaccines, adjuvanted with AS01 or AS03 or non-adjuvanted: a phase 1–2 randomised controlled trial

Nicolas Folschweiller, Carline Vanden Abeele, Laurence Chu, Pierre Van Damme, Adolfo Garcı́a-Sastre, Florian Krammer, Raffael Nachbagauer, Peter Palese, Alicia Solórzano, Dan Bi,

The Lancet Infectious Diseases · 2022 · 29 citations · 24 references

DOI

Concepts

References

24

A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial

Raffael Nachbagauer, Jodi Feser, Abdollah Naficy et al. · Nature Medicine · 2020 · 342 citations · Full text

, , +10

Defining B cell immunodominance to viruses

Davide Angeletti, James S. Gibbs, Matthew Angel et al. · Nature Immunology · 2017 · 270 citations · Full text

, , +7

The influenza virus hemagglutinin head evolves faster than the stalk domain

Ericka Kirkpatrick, Xueting Qiu, Patrick C. Wilson et al. · Scientific Reports · 2018 · 238 citations · Full text

Novel correlates of protection against pandemic H1N1 influenza A virus infection

Sophia Ng, Raffael Nachbagauer, Ángel Balmaseda et al. · Nature Medicine · 2019 · 194 citations

, , +7

Genome-wide mutagenesis of influenza virus reveals unique plasticity of the hemagglutinin and NS1 proteins

Nicholas S. Heaton, David Sachs, Chi-Jene Chen et al. · Proceedings of the National Academy of Sciences · 2013 · 189 citations · Full text

, , +14